| Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... The Lancet Neurology 12 (4), 357-367, 2013 | 2360 | 2013 |
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ... Neurobiology of aging 31 (8), 1275-1283, 2010 | 1137 | 2010 |
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ... Annals of neurology 69 (1), 181-192, 2011 | 1026 | 2011 |
| Apparent fibre density: a novel measure for the analysis of diffusion-weighted magnetic resonance images D Raffelt, JD Tournier, S Rose, GR Ridgway, R Henderson, S Crozier, ... Neuroimage 59 (4), 3976-3994, 2012 | 646 | 2012 |
| Relationship between atrophy and β‐amyloid deposition in Alzheimer disease G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ... Annals of neurology 67 (3), 317-324, 2010 | 457 | 2010 |
| An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy JA Dowling, J Lambert, J Parker, O Salvado, J Fripp, A Capp, C Wratten, ... International Journal of Radiation Oncology* Biology* Physics 83 (1), e5-e11, 2012 | 377 | 2012 |
| Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease S Frost, Y Kanagasingam, H Sohrabi, J Vignarajan, P Bourgeat, ... Translational psychiatry 3 (2), e233-e233, 2013 | 330 | 2013 |
| Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective … VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... Lancet Neurol 12 (4), 357-367, 2013 | 311 | 2013 |
| Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ... Brain 135 (7), 2126-2139, 2012 | 299 | 2012 |
| Symmetric diffeomorphic registration of fibre orientation distributions D Raffelt, JD Tournier, J Fripp, S Crozier, A Connelly, O Salvado NeuroImage 56 (3), 1171-1180, 2011 | 296 | 2011 |
| Fibre-specific white matter reductions in Alzheimer’s disease and mild cognitive impairment R Mito, D Raffelt, T Dhollander, DN Vaughan, JD Tournier, O Salvado, ... Brain 141 (3), 888-902, 2018 | 287 | 2018 |
| Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline S Ayton, A Fazlollahi, P Bourgeat, P Raniga, A Ng, YY Lim, I Diouf, ... Brain 140 (8), 2112-2119, 2017 | 259 | 2017 |
| β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ... Neurology 74 (2), 121-127, 2010 | 257 | 2010 |
| Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ... Annals of neurology 74 (6), 905-913, 2013 | 254 | 2013 |
| Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a … SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ... The Lancet Neurology 15 (10), 1044-1053, 2016 | 232 | 2016 |
| Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease V Doré, VL Villemagne, P Bourgeat, J Fripp, O Acosta, G Chetélat, L Zhou, ... JAMA neurology 70 (7), 903-911, 2013 | 213 | 2013 |
| MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planning J Lambert, PB Greer, F Menk, J Patterson, J Parker, K Dahl, S Gupta, ... Radiotherapy and Oncology 98 (3), 330-334, 2011 | 177 | 2011 |
| Larger temporal volume in elderly with high versus low beta-amyloid deposition G Chetelat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ... Brain 133 (11), 3349-3358, 2010 | 170 | 2010 |
| Larger temporal volume in asymptomatic elderly with high versus low beta-amyloid deposition G Chetelat, V Villemagne, K Pike, JC Baron, P Bourgeat, G Jones, K Ellis, ... Alzheimer's & Dementia: The Journal of the Alzheimer's Association 6 (4), S2-S3, 2010 | 170* | 2010 |
| Incidence of cerebral microbleeds in preclinical Alzheimer disease PA Yates, PM Desmond, PM Phal, C Steward, C Szoeke, O Salvado, ... Neurology 82 (14), 1266-1273, 2014 | 168 | 2014 |
Christopher Cleon RoweUniversity of MelbourneAdresse e-mail validée de austin.org.au